Learn more

BIOLEADERS CORP

Overview
  • Total Patents
    195
  • GoodIP Patent Rank
    47,773
  • Filing trend
    ⇧ 20.0%
About

BIOLEADERS CORP has a total of 195 patent applications. It increased the IP activity by 20.0%. Its first patent ever was published in 2001. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SUNG MOON-HEE, SHANGHAI HEP PHARMACEUTICAL CO LTD and MARIA VON MED BIOTECHNOLOGY CO LTD.

Patent filings per year

Chart showing BIOLEADERS CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sung Moon Hee 73
#2 Sung Moon-Hee 69
#3 Kim Chul Joong 57
#4 Poo Ha Ryoung 43
#5 Hong Seung Pyo 43
#6 Poo Haryoung 37
#7 Park Chung 31
#8 Choi Jae Chul 30
#9 Lee Il Han 26
#10 Hong Seung-Pyo 25

Latest patents

Publication Filing date Title
KR20200062103A Composition containing Poly-Gamma-Glutamate or a salt there of for improving women's vaginal health
WO2020076079A2 Surface expression vector using two kinds of promoters derived from lactobacillus casei for concurrently expressing two target proteins and method for expressing proteins on microbial surface by using same
WO2020076078A1 Surface expression vector for constitutive high-expression using promoter of galactose mutarotase gene derived from lactobacillus casei, and use thereof
KR20200001001A SURFACE EXPRESSION VECTORS INCLUDING pgsA, GENE ENCODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND METHOD OF USING VECTORS TO EXPRESS TARGET PROTEIN ON SURFACE OF MICROORGANISM
KR20200000972A SURFACE EXPRESSION VECTORS INCLUDING pgsA, GENE ENCODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND METHOD OF USING VECTORS TO EXPRESS TARGET PROTEIN ON SURFACE OF MICROORGANISM
KR20200001036A SURFACE EXPRESSION VECTORS INCLUDING pgsA, GENE ENCODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND METHOD OF USING VECTORS TO EXPRESS TARGET PROTEIN ON SURFACE OF MICROORGANISM
KR20190132153A Composition containing Poly-Gamma-Glutamate or a salt there of for improving women's vaginal health
KR20190012337A Cosmetic Composition Containing Fermented Soy Bean Milk for Antioxidant and for Improvement of atopy
KR20190012336A Method for Preparing Fermented Soy Bean Milk
KR20180070871A Composition for Improving Symptom of Atopic Skin Containing Poly-Gamma-glutamic Acid
KR20180050093A Composition for Prebiotics Containing Poly-Gamma-Glutamate
KR20180045153A Vaccine Comprising Poly-Gamma-Glutamate/Chitosan sM2HA2 Nanoparticle or Poly-Gamma-Glutamate/Chitosan sM2HA2CTA1 Nanoparticle
KR20170123767A Method of Preparing Polygammaglutamic Acid-Chitosan Nanoparticles
KR101765600B1 USE of Poly-gamma-glutamic Acid for Treating Cervical Intraepithelial Neoplasia
KR20170109454A Composition and Method of Probiotics Stabilization Comprising Poly-Gamma-Glutamic Acid
KR20170046036A Vaccine Comprising Poly-Gamma-Glutamate/Chitosan Nanoparticle and Inactivated Enterovirus 71
KR101525180B1 Cell Surface Expression Vector for Influenza Virus Antigen and Microorganisms Transformed Thereby
WO2016056681A1 Cell surface expression vector of influenza virus antigen, and microorganism transformed thereby
KR20150120133A Composition for Food Stabilizer Comprising Poly-Gamma-Glutamic Acid
KR20150115303A Composition for Wound Healing Comprising Poly-Gamma-Glutamic Acid